CAR-T Cells are hardly new. What’s new is the receptor that allows the T Cell to
target a variety of cancer cell lines without targeting healthy cells. But they’ve only done work in highly immuno-compromised mice, so we’ll see how this translates to larger mammals and more sophisticated in vivo systems first.
This message has been modified
Originally posted on Jan 22, 2020 at 7:52:33am
Message modified by ldssdl on Jan 22, 2020 at 7:53:38am